Dihydropyrimidine dehydrogenase pharmacogenetics for predicting fluoropyrimidine-related toxicity in the randomised, phase III adjuvant TOSCA trial in high-risk colon cancer patients
2017 ◽
Vol 117
(9)
◽
pp. 1269-1277
◽
Keyword(s):